stemline therapeutics inc
(STML:Consolidated Issue listed on NASDAQ Capital Market)
Ivan Bergstein M.D.
Founder, Chairman, Chief Executive Officer and President ,Stemline Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 9 board members in 1 different organizations across 1 different industries.|
See Board Relationships
As of Fiscal Year 2014
Dr. Ivan Bergstein, M.D. founded Stemline Therapeutics, Inc., in August 2003 and has been its Chairman, President and Chief Executive Officer since August 2003. Dr. Bergstein served as the Medical Director of Keryx Biopharmaceuticals, Inc., (formerly Access Oncology, Inc.), where he was a key member of the team that in-licensed and developed several clinical stage oncology compounds. Prior to this, he served as Senior Biopharmaceuticals Analyst at Cancer Advisors (now ...
750 Lexington AvenuePhone: 646-502-2311
New York, New York 10022
Board Members Memberships*
Founder, Chairman, Chief Executive Officer and President
The University of Pennsylvania
Mount Sinai NYU Health
|There is no Competitor Compensation data available.|